Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
γH2AX DNA Damage Detection Kit for FLASH-RT
2026-09-09
Translate radiation- and treatment-induced DNA damage into measurable red γ-H2AX foci with a practical immunofluorescence workflow. The assay supports radiosensitization studies, DNA repair kinetics, apoptosis assay design, and genotoxicity assessment across mammalian cells and tissues.
Measuring Cancer Drug Response Beyond Relative Viability
2026-09-09
Hannah Schwartz’s dissertation shows why relative viability and cell killing should not be treated as interchangeable measurements in cancer research. Its framework emphasizes response magnitude, timing, and orthogonal validation, providing a practical basis for designing more interpretable drug-response and apoptosis assays.
NADH as a Redox Lens for Mechanistic Research
2026-09-08
NADH is more than an electron donor: it is a practical redox variable for connecting metabolism with mechanistic biology. This article explains how to integrate reduced nicotinamide adenine dinucleotide into osteoclast, mitochondrial, disease-modeling, and photocatalytic assays without confusing correlation with causation.
Fenipentol in Chuanxiong: A CHD Mechanism Study
2026-09-08
The reference study distinguishes the volatile chemistry and predicted pharmacology of Chuanxiong cortex and pith rather than treating the rhizome as a uniform material. By combining SPME-GC×GC-MS, network pharmacology, pathway analysis, and molecular docking, it identifies Fenipentol among the principal cortex-associated compounds and provides a framework for tissue-specific investigation of coronary heart disease mechanisms.
Acifran: Structural Strategy for Lipid Signaling
2026-09-07
Acifran is emerging as more than a receptor agonist: it is a practical mechanistic probe for comparing HCAR2/GPR109A and HCAR3/GPR109B signaling. Recent cryo-EM structures provide a rational framework for assay design, translational risk assessment, and structure-guided lipid metabolism research.
Paclitaxel and Lysosomal Stress in Cancer Research
2026-09-07
Paclitaxel (Taxol) is best known for stabilizing microtubules and producing mitotic arrest, but it can also serve as a carefully controlled perturbation tool for studying organelle stress. This article connects paclitaxel assay design with new evidence for TECPR1-mediated lysosomal repair, emphasizing mechanistic controls and interpretation limits.
KG-501 for CREB–CBP Mechanistic Assays
2026-09-05
KG-501 is a practical chemical probe for testing CREB–CBP and Myb–KIX transcriptional coactivator disruption in cell-based workflows. This guide translates its use in macrophage and colorectal cancer pathway studies into dose-planning, assay-selection, and troubleshooting strategies.
Propranolol in Regeneration Research: Practical Workflows
2026-09-04
Use Propranolol as a controlled β-adrenergic perturbation across cardiovascular, neurobehavioral, metabolic, and exploratory inner-ear regeneration assays. This guide combines solvent handling, dose design, multiplex tissue readouts, and troubleshooting so researchers can separate receptor-mediated effects from injury, vehicle, and systemic confounders.
Cy5 Hydrazide: Carbonyl Assays in Nanoparticles
2026-09-04
Cy5 hydrazide combines carbonyl-selective chemistry with far-red fluorescence for protein carbonylation labeling and biomolecule analysis. This guide focuses on a less-discussed challenge: separating true chemical labeling from nanoparticle association, aggregation, and imaging artifacts.
ω-Agatoxin IVA TFA in Cav2.1 Workflows
2026-09-03
ω-Agatoxin IVA TFA enables selective interrogation of Cav2.1-dependent calcium entry, synaptic release, and seizure-related circuit activity. Its value is greatest when concentration, voltage protocol, and channel subtype are interpreted together rather than treating every toxin-sensitive current as a single P-type population.
ATRX-Deficient Glioma and RTK Inhibitor Sensitivity
2026-09-03
The reference study identifies ATRX deficiency as a cellular vulnerability to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma models. Its combination data further indicate that ATRX status may help interpret RTK inhibitor responses when these agents are paired with temozolomide, although clinical validation remains necessary.
Liproxstatin-1 for Ferroptosis Research
2026-09-02
Liproxstatin-1 is a potent ferroptosis inhibitor for separating iron-dependent lipid damage from apoptosis and nonspecific oxidative stress. This workflow shows how to use it in GPX4-deficient cell protection, renal injury studies, and emerging salivary gland models while avoiding common assay artifacts.
Deuterated Tetrazole CYP51 Inhibitor V23: Study Insights
2026-09-02
The 2025 European Journal of Medicinal Chemistry study describes V23, a deuterated tetrazole CYP51 inhibitor developed to improve antifungal breadth, resistance activity, human CYP selectivity, and metabolic stability. Its combined biochemical, microbiological, cellular, and in vivo data position V23 as a promising lead for invasive fungal infection research, while also highlighting the challenges of translating early pharmacodynamic findings into clinical development.
Deferiprone for Iron-Stress Metabolism Studies
2026-09-01
Deferiprone enables controlled iron depletion without relying on DMSO or ethanol, making it useful for enterocyte metabolism, cancer biology, oxidative stress, and apoptosis studies. This guide translates recent IPEC-J2 findings into practical assay designs, controls, optimization steps, and troubleshooting strategies.
Azilsartan Medoxomil: Assay Design Guide
2026-09-01
Azilsartan medoxomil monopotassium is a powerful tool for connecting sustained AT1 receptor antagonism with experimental blood pressure endpoints. This guide translates TAK 491 pharmacology and 2024 network meta-analysis evidence into practical assay and protocol decisions.
8169 records 9/545 page Previous Next First page 上5页 678910 下5页 Last page